Modulation of Adriamycin Resistance in Human Breast Carcinoma MCF‐7 Cells in vitro and in vivo by Medroxyprogesterone Acetate

The combination effect of adriamycin (ADM) and medroxyprogesterone acetate (MPA) was examined in vitro against human breast carcinoma MCF‐7 and its ADM‐resistant line (MCF‐7/ADM). MCF‐7 cells, which are positive for estrogen receptors, progesterone receptors and high‐affinity MPA‐binding activity, w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Jpn J Cancer Res
Main Authors: Ishida, Hiroyuki, Okabe, Masami, Gomi, Katsushige, Horiuchi, Ryuya, Mikami, Koji, Naito, Mikihiko, Tsuruo, Takashi
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 1994
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5919497/
https://ncbi.nlm.nih.gov/pubmed/8014112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1994.tb02393.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares